|

RD133 Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 2

Top Sponsors

  • Tongji Hospital1
  • The First Affiliated Hospital with Nanjing Medical University1

Indications

  • Cancer2
  • Solid Tumor1

Other2 trials

An Exploratory Clinical Study of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
Early 1
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.